Analysis of screening results of liver cancer early diagnosis and treatment project in Wuhe County of Anhui Province from 2013 to 2022

ZHANG Jing; CHEN Xiaoyu

doi:10.19837/j.cnki.ahyf.2023.04.011

PDF(774 KB)

Anhui Journal of Preventive Medicine ›› 2023, Vol. 29 ›› Issue (4) : 312-316. DOI: 10.19837/j.cnki.ahyf.2023.04.011

Analysis of screening results of liver cancer early diagnosis and treatment project in Wuhe County of Anhui Province from 2013 to 2022

ZHANG Jing¹, CHEN Xiaoyu²

Author information +

History +

Abstract

Objective To analyze the data of early diagnosis and treatment of liver cancer project in Wuhe County from 2013 to 2022,to understand the distribution of related risk factors of liver cancer,and to provide evidence for health education and health promotion. Methods A questionnaire survey and blood sample collection were conducted among permanent residents (males aged 35-64 and females aged 45-64) from six towns in Wuhe County from 2013 to 2022.Statistical analysis was conducted using SPSS 23.0. Results A total of 75 liver cancer patients were screened from 111 713 subjects,the detection rate of liver cancer was 0.50%.There were statistically significant differences in gender (χ²=6.586,P=0.037),water intake (χ²=21.473,P=0.002),alcohol consumption (χ²=11.328,P=0.003),age(χ²=59.133,P<0.001) and family history (χ²=34.316,P<0.001) between liver cancer patients and non liver cancer patients. Conclusion The early diagnosis and treatment project for liver cancer in the Huaihe River Basin of Wuhe County has a low detection rate of liver cancer.

Key words

Liver cancer / Huaihe River Basin / Early diagnosis and treatment

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

ZHANG Jing, CHEN Xiaoyu. Analysis of screening results of liver cancer early diagnosis and treatment project in Wuhe County of Anhui Province from 2013 to 2022[J]. Anhui Journal of Preventive Medicine. 2023, 29(4): 312-316 https://doi.org/10.19837/j.cnki.ahyf.2023.04.011

References

[1] Tapper E,Parikh N.Mortality due to cirrhosis and liver cancer in the United States,1999-2016: Observational study [J].BMJ Clinical Research,2018,362:k2817.
[2] Tapper E,Asrani S.The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care [J].J Hepatol,2020,73(2):441-445.
[3] 杨帆,曹毛毛,李贺,等.1990—2019年中国人群肝癌流行病学趋势分析及预测 [J].中华消化外科杂志,2022,21(1): 106-113.
[4] 孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析 [J].中国肿瘤,2019,28(1): 1-11.
[5] 刘志荣,陈叶纪.2016安徽省肿瘤登记年报 [M].合肥: 合肥工业大学出版社,2017.
[6] Gandhi M,Ling H,Chen C,et al.Impact of COVID-19 on hepatocellular carcinoma management: a multicountry and region study [J].J Hepatocell Carcinoma,2021(8):1159-1167.
[7] Casoria F,Galeotti F,Villeval M.Perceived social norm and behavior quickly adjusted to legal changes during the COVID-19 pandemic in France [J].J Econ Behav Organ,2021(190):54-65.
[8] Christopher P,Tse-Ling F,Juanjuan Z,et al.Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California,1988-2012 [J].J Natl Cancer Inst,2018,110(11):1259-1269.
[9] Venook A,Papandreou C,Furuse J,et al.The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective [J].Oncologist,2010,15(4):5-13.
[10] 孙晓琨.近四十年来我国消化系统癌症的发病状况及其危险因素研究[D].遵义:遵义医科大学,2021.
[11] 郑莉,戴丹,王志强.2011—2016年安徽省淮河流域恶性肿瘤发病与死亡分析 [J].环境卫生学杂志,2021,11(6): 501-505+518.
[12] 卫生部疾病预防控制局.癌症早诊早治项目技术方案: 2011年版[M].北京:人民卫生出版社,2011.
[13] 梁岭,吕逸丽,王华东.安徽省淮河流域癌症筛查的发展现状与展望 [J].中国肿瘤,2022,31(9): 679-682.
[14] 查震球.2015—2018年安徽省癌症早诊早治项目农村地区肝癌筛查分析 [J].中国肿瘤,2019,28(10): 743-748.
[15] 康瑞华,刘曙正,陈琼,等.河南省淮河流域癌症筛查与早诊早治工作进展与展望 [J].中国肿瘤,2022,31(11): 847-852.
[16] 曹毛毛,陈万青.推进农村地区癌症早诊早治提高居民健康水平[J].中国肿瘤,2022,31(12): 937-940.
[17] 马恒敏,李晓,韩洪冰,等.2007—2021年山东省淮河流域癌症早诊早治项目筛查结果初步分析 [J].中国肿瘤,2022,31(10): 759-765.
[18] Tovo V,Mattos D,Coral P,et al.Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis [J].World J Gastroenterol,2023,29(2):343-356.
[19] Liakina V,Strainiene S,Stundiene I,et al.Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis [J].World J Hepatol,2022,14(7):1277-1290.
[20] Li S,Han L,He Y,et al.Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis [J].World J Hepatol,2022,14(12):1997-2011.
[21] Gao B,Seo W,Gao Y,et al.Aldehyde dehydrogenase 2 suppresses cirrhosis and alcohol-induced hepatocellular carcinoma via the inhibition of acetaldehyde-derived DNA damage and multiple oncogenic signaling pathways [J].Cancer Biol Med,2018,15(S1):14.
[22] Tai J,Harrison P,Chen H,et al.Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer,low comorbidity in hepatitis B virus [J].World J Gastroenterol,2023,29(14):2188-2201.
[23] Chen C,Liang K,Chang A,et al.Effects of hepatitis B virus,alcohol drinking,cigarette smoking and familial tendency on hepatocellular carcinoma [J].Hepatology,1991,13(3):398-406.
[24] Li S,Han L,He Y,et al.Immunological classification of hepatitis B virus-positive hepatocellular carcinoma by transcriptome analysis [J].World J Hepatol,2022,14(12):1997-2011.
[25] Loomba R,Liu J,Yang H,et al.Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma [J].Clin Gastroenterol Hepatol,2013,1636-1645+e3.
[26] 孟金霞,卢喜玲,别文倩,等.乙肝肝硬化并发原发性肝癌的相关危险因素分析[J].实用癌症杂志,2022,37(5):777-779.
[27] 吴婷,万崇华,杨铮,等.影响肝癌患者报告结局与生命质量的遗传因素初探[J].广东医科大学学报,2020,38(5):532-536.
[28] Atkins J,Pilling L,Masoli J,et al.Association of hemochromatosis HFE p.C282Y homozygosity with hepatic malignancy [J].JAMA,2020,324(20):2048.
[29] 陈悦.1990—2019年中国肝癌流行趋势及大学生肝癌知信行调查研究[D].衡阳:南华大学,2022.
[30] 贺小琴,宋孝美,郭进军.乙肝病毒感染与乙肝相关肝癌疾病发展的综述[J].科学咨询(科技·管理),2018,580(4):53-55.
[31] 贺小琴.乙肝病毒感染与乙肝相关性肝癌疾病发展的关系[D].重庆:重庆医科大学,2018.
[32] 王欣,宋乐,方昕,等.182例患者乙肝病毒基因分型与原发性肝癌的关系[J].公共卫生与预防医学,2022,33(4):141-143.
[33] 徐蓉,华忠.肝硬化并发原发性肝癌的流行病学特征、危险因素及相关预防干预对策研究[J].中西医结合肝病杂志,2020,30(4):357-359+366.